chr12-64621464-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_178169.4(RASSF3):c.111+10721G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.498 in 151,892 control chromosomes in the GnomAD database, including 19,033 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 19033 hom., cov: 31)
Consequence
RASSF3
NM_178169.4 intron
NM_178169.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.38
Publications
4 publications found
Genes affected
RASSF3 (HGNC:14271): (Ras association domain family member 3) The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.[supplied by OMIM, Jul 2003]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.52 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RASSF3 | ENST00000542104.6 | c.111+10721G>A | intron_variant | Intron 1 of 4 | 1 | NM_178169.4 | ENSP00000443021.1 | |||
| RASSF3 | ENST00000637125.1 | c.295-63323G>A | intron_variant | Intron 2 of 5 | 5 | ENSP00000490100.1 | ||||
| RASSF3 | ENST00000283172.9 | n.111+10721G>A | intron_variant | Intron 1 of 3 | 2 | ENSP00000283172.4 |
Frequencies
GnomAD3 genomes AF: 0.498 AC: 75624AN: 151776Hom.: 19019 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
75624
AN:
151776
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.498 AC: 75669AN: 151892Hom.: 19033 Cov.: 31 AF XY: 0.491 AC XY: 36476AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
75669
AN:
151892
Hom.:
Cov.:
31
AF XY:
AC XY:
36476
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
20788
AN:
41396
American (AMR)
AF:
AC:
7389
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
AC:
1750
AN:
3464
East Asian (EAS)
AF:
AC:
1314
AN:
5164
South Asian (SAS)
AF:
AC:
2227
AN:
4824
European-Finnish (FIN)
AF:
AC:
4992
AN:
10542
Middle Eastern (MID)
AF:
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35619
AN:
67960
Other (OTH)
AF:
AC:
1023
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1928
3856
5785
7713
9641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1346
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.